Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3417-3421

  McNeil, Lisa K ^a   Murphy, Ellen ^a   Zhao, Xiao Juan ^a   Guttmann, Stephen ^a   Harris, Shannon L ^a   Scott, Adrienne A ^a   Tan, Cuiwen ^a   Mack, Michelle ^a   DaSilva, Ida ^a   Alexander, Kristin ^a   Mason, Kathryn ^a   Jiang, Han Qing ^a   Zhu, Duzhang ^a   Mininni, Terri L ^a   Zlotnick, Gary W ^a   Hoiseth, Susan K ^a   Jones, Thomas R ^a   Pride, Michael W ^a   Jansen, Kathrin U ^a   Anderson, Annaliesa S ^a  

^a WYETH RESEARCH   (United States)

Author keywords

Capsule; LP2086; Neisseria meningitidis serogroup B

Indexed keywords

ANTISERUM; LP2086 PROTEIN; LP2086 PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; OUTER MEMBRANE PROTEIN; POLYSACCHARIDE; SEROGROUP B POLYSACCHARIDE; SEROGROUP B POLYSACCHARIDE ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL SURFACE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; LYSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BLOOD BACTERICIDAL ACTIVITY; FEMALE; HUMANS; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP B; RABBITS;

EID: 67349208408     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.075     Document Type: Article

References (17)

1. Rosenstein N.E., Perkins B.A., Stephens D.S., Popovic T., and Hughes J.M. Meningococcal disease. New Engl J Med 344 18 (2001) 1378-1388
2. Zimmer S.M., and Stephens D.S. Meningococcal conjugate vaccines. Expert Opin Pharmacother 5 4 (2004) 855-863
3. EU-INS. Invasive Neisseria meningitides in Europe 2006 Health Protection Agency. London; 2006. www.euibis.org.
4. Centers for Disease Control A, GA. Active Bacterial Core Surveillance. http://www.cdc.gov/ncidod/dbmd/abcs/meth-surv-pop.htm.
5. Bruge J., Bouveret-Le Cam N., Danve B., Rougon G., and Schulz D. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers. Vaccine 22 9-10 (2004) 1087-1096
6. Finne J., Bitter-Suermann D., Goridis C., and Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 138 12 (1987) 4402-4407
7. Finne J., Leinonen M., and Makela P.H. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2 8346 (1983) 355-357
8. Bernfield L., Fletcher L., Howell A., Farley J., Zagursky R., Knauf M., et al. Identification of a novel vaccine candidate for group B Neisseria meningitidis. Proceedings of the 13th international pathogenic Neisseria conference. Oslo, Norway, 2002 (2002) 116
9. Farley J., Fletcher L., Bernfield L., Howell A., Knauf M., Weise P., et al. Characterization, cloning and expression of different subfamilies of the ORF 2086 gene from Neisseria meningitidis. Proceedings of the 13th international pathogenic Neisseria conference. Oslo, Norway, 2002 (2002) 124
10. Fletcher L.D., Bernfield L., Barniak V., Farley J.E., Howell A., Knauf M., et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 72 4 (2004) 2088-2100
11. Nissen M.D., Marshall H.S., Richmond P., Lambert S.B., Roberton D., Gruber W.C., et al. A randomized, placebo-controlled, double-blind, phase 1 trial of ascending doses of meningococcal group B rLP2086 vaccine. Proceedings of the 26th annual meeting of the European Society for Paediatric Infectious Diseases. Graz, Austria, 2008 (2008)
12. Schneider M.C., Exley R.M., Chan H., Feavers I., Kang Y.H., Sim R.B., et al. Functional significance of factor H binding to Neisseria meningitidis. J Immunol 176 12 (2006) 7566-7575
13. Madico G., Welsch J.A., Lewis L.A., McNaughton A., Perlman D.H., Costello C.E., et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177 1 (2006) 501-510
14. Murphy E., Andrew L., Lee K.-L., Ambrose K., Dilts D., Borrow R., et al. Sequence diversity of vaccine candidate LP2086 in Neisseria meningitidis serogroup B strains causing invasive disease. Proceedings of the 16th international pathogenic Neisseria conference. Rotterdam, The Netherlands, 7-12 September, 2008 (2008)
15. Hoiseth S.K., Murphy E., Andrew L., Lee K.-L., Ambrose K., Dilts D., et al. LP2086 and MLST distribution in epidemiologically relevant strains of serogroup B Neisseria meningitides. Proceedings of the 16th international pathogenic Neisseria conference. Rotterdam, The Netherlands, 2008 (2008)
16. Tsang R.S., and Zollinger W.D. Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 12 1 (2005) 152-156
17. Liu X., Wang S., Sendi L., and Caulfield M.J. High-throughput imaging of bacterial colonies grown on filter plates with application to serum bactericidal assays. J Immunol Methods 292 1-2 (2004) 187-193